by Seroconversion of the guinea pigs in our H5N1 avian influenza virus transmission studies. (DKGX/35) and A/bar-headed goose/Qinghai/3/2005(BHGQH/05), were transmitted from inoculated animals to nave contact animals. Our mutagenesis analysis revealed that this amino acid asparagine (Asn) at Pamapimod (R-1503) position 701 in the Pamapimod (R-1503) PB2 protein was a prerequisite for DKGX/35 transmission in guinea pigs. In addition, an amino acid change in the hemagglutinin (HA) protein (Thr160Ala), resulting in the loss of glycosylation at 158160, was responsible for HA binding to sialylated glycans and was critical for H5N1 virus transmission in guinea pigs. These amino acids changes in PB2 and HA could serve as important molecular markers for assessing the pandemic potential of H5N1 field isolates. == Author Summary == H5N1 influenza viruses have caused over 400 human infections in 15 countries and continue to circulate in poultry and wild birds. Most human infections resulted from direct contact with virus-contaminated poultry or poultry products. It would be disastrous if H5N1 viruses acquired the ability to efficiently transmit among humans, because the mortality rate may exceed 60%. However, the genetic basis for transmission of H5N1 influenza viruses is largely unknown. Here, we demonstrate that this amino acid residue Pamapimod (R-1503) at 701 of PB2 is usually a prerequisite for transmission of H5N1 viruses in a mammalian guinea pig model. Interestingly, we found that the absence of glycosylation at residues 158160 of the HA gene is usually pivotal for the H5N1 virus to bind to human-like receptors and to transmit in a mammal host. These findings are important for assessing the pandemic potential of H5N1 field isolates. == Introduction == The H5N1 avian influenza viruses (AIVs) have drawn extensive attention for their deadly impact on both animals and humans. The number of people who have been subclinically infected with H5N1 viruses is very limited[1], and H5N1 AIVs have a 60% fatality rate in humans (World Health Organization [WHO];http://www.who.int). H5N1 AIVs first surfaced in China in 1996[2], with chicken-lethal and avirulent strains being isolated from geese in Guangdong province[3]. In 1997, a reassortant H5N1 AIV that carried the HA gene from an A/goose/Guangdong/1/96-like virus caused an outbreak of disease in poultry in Hong Kong and crossed over into humans, resulting in 18 cases of contamination with six deaths[4],[5]. In 2003 and 2004, H5N1 AIVs infected poultry and humans in numerous countries of southeastern Asia[6]. In 2005, several genotypes of H5N1 AIV caused outbreaks in wild migratory birds at Qinghai Lake in western China, and one genotype spread widely to different Npy species across a wide geographic area that included Europe and Africa[7]. To date, H5N1 AIVs have caused disease in more than 60 countries (Office International des Epizooties [OIE];http://www.oie.int), with cases of human contamination being reported in 15 countries (World Health Organization [WHO];http://www.who.int). Despite substantial efforts to control these outbreaks, H5N1 AIVs have continued to evolve and spread, perpetuating the fear of an influenza pandemic if these viruses acquire the ability to transmit efficiently among humans. Understanding the genetic determinants that control H5N1 AIV transmission in mammalian hosts will help protect public health. The transmissibility of influenza viruses is determined by the Pamapimod (R-1503) virus, environmental factors, and host factors[8][11]. The viral traits governing transmission efficiency have not been well characterized. The affinity of the viral HA protein for sialic acid -2,6 linked glycan (-2,6 glycan) is necessary for transmission of the 1918 H1N1 influenza virus between ferrets[9]. The viral polymerase complex is also involved in determining viral host range, replication and Pamapimod (R-1503) pathogenicity[12][15]and plays a role in transmission[16],[17]. Cold and dry environmental conditions favor the transmission of human influenza virus in guinea pigs[10],[11]. Host factors also affect replication and transmission of influenza viruses. Under experimental conditions, AIVs do not replicate efficiently in humans[18], and human viruses do not replicate efficiently in ducks[19]. In one study, the human upper airway tract was reported to contain cells that predominantly communicate -2,6 glycan[20], a host that mementos the transmitting and replication of human being influenza infections, which bind to -2 preferentially,6 glycans. Nevertheless, in another scholarly study, infections with preferential binding to -2,3 glycans had been reported to bind to cells in the human being upper respiratory system[21]. The.
